Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study

被引:74
作者
Thomassin-Naggara, Isabelle [1 ,3 ,5 ]
Balvay, Daniel [3 ]
Aubert, Emilie [5 ]
Darai, Emile [4 ]
Rouzier, Roman [4 ]
Cuenod, Charles A. [2 ,3 ]
Bazot, Marc [5 ]
机构
[1] Hop Tenon, Serv Radiol, F-75020 Paris, France
[2] HEGP, Dept Radiol, Paris, France
[3] Univ Paris 05, INSERM, UMR 970, Lab Rech Imagerie, Paris, France
[4] Hop Tenon, AP HP, Dept Gynaecol Obstet, F-75020 Paris, France
[5] Hop Tenon, AP HP, Dept Radiol, F-75020 Paris, France
关键词
Perfusion; MRI; Complex adnexal masses; Dynamic contrast-enhanced MRI; Ovarian tumour; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-BLOOD-FLOW; PERITONEAL DISSEMINATION; OVARIAN-TUMORS; PERMEABILITY; DIFFUSION; PERFUSION; CHEMOTHERAPY; VALIDATION; CANCER;
D O I
10.1007/s00330-011-2329-6
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
To evaluate the ability of quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to differentiate malignant from benign adnexal tumours. Fifty-six women with 38 malignant and 18 benign tumours underwent MR imaging before surgery for complex adnexal masses. Microvascular parameters were extracted from high temporal resolution DCE-MRI series, using a pharmacokinetic model in the solid tissue of adnexal tumours. These parameters were tissue blood flow (F-T), blood volume fraction (Vb), permeability-surface area product (PS), interstitial volume fraction (Ve), lag time (Dt) and area under the enhancing curve (rAUC). Area under the receiver operating curve (AUROC) was calculated as a descriptive tool to assess the overall discrimination of parameters. Malignant tumours displayed higher F-T, Vb, rAUC and lower Ve than benign tumours (P < 0.0001, P = 0.0006, P = 0.04 and P = 0.0002, respectively). F-T was the most relevant factor for discriminating malignant from benign tumours (AUROC = 0.86). Primary ovarian invasive tumours displayed higher F-T and shorter Dt than borderline tumours. Malignant adnexal tumours with associated peritoneal carcinomatosis at surgery displayed a shorter Dt than those without peritoneal carcinomatosis at surgery (P = 0.01). Quantitative DCE-MRI is a feasible and accurate technique to differentiate malignant from benign adnexal tumours and could potentially help oncologists with management decisions. aEuro cent Quantitative DCE MR imaging allows accurate differentiation between malignant and benign tumours aEuro cent Quantitative DCE MRI may help predict peritoneal carcinomatosis associated with ovarian tumors aEuro cent Quantitative DCE MRI helps distinguish between invasive and borderline primary ovarian tumours.
引用
收藏
页码:738 / 745
页数:8
相关论文
共 36 条
[11]   VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma [J].
Chen, HZ ;
Ye, DF ;
Xie, X ;
Chen, BY ;
Lu, WG .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :630-635
[12]   Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma [J].
de Bazelaire, C ;
Siauve, N ;
Fournier, L ;
Frouin, F ;
Robert, P ;
Clement, O ;
de Kerviler, E ;
Cuenod, CA .
EUROPEAN RADIOLOGY, 2005, 15 (12) :2497-2505
[13]  
FLEISCHER AC, 1993, J ULTRAS MED, V12, P41
[14]   Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging [J].
Fujii, Shinva ;
Matsusue, Eiji ;
Kanasaki, Yoshiko ;
Kanamori, Yasunobu ;
Nakanishi, Junko ;
Sugihara, Shuji ;
Kigawa, Junzo ;
Terakawa, Naoki ;
Ogawa, Toshihide .
EUROPEAN RADIOLOGY, 2008, 18 (01) :18-23
[15]   IN-VIVO QUANTIFICATION OF THE UNIDIRECTIONAL INFLUX CONSTANT FOR GD-DTPA DIFFUSION ACROSS THE MYOCARDIAL CAPILLARIES WITH MR-IMAGING [J].
LARSSON, HBW ;
STUBGAARD, M ;
SONDERGAARD, L ;
HENRIKSEN, O .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 1994, 4 (03) :433-440
[16]   Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy [J].
Mitchell, C. L. ;
O'Connor, J. P. B. ;
Jackson, A. ;
Parker, G. J. M. ;
Roberts, C. ;
Watson, Y. ;
Cheung, S. ;
Davies, K. ;
Buonaccorsi, G. A. ;
Clamp, A. R. ;
Hasan, J. ;
Byrd, L. ;
Backen, A. ;
Dive, C. ;
Jayson, G. C. .
ANNALS OF ONCOLOGY, 2010, 21 (10) :1982-1989
[17]   DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents [J].
O'Connor, J. P. B. ;
Jackson, A. ;
Parker, G. J. M. ;
Jayson, G. C. .
BRITISH JOURNAL OF CANCER, 2007, 96 (02) :189-195
[18]  
Padhani Anwar R, 2004, Top Magn Reson Imaging, V15, P41, DOI 10.1097/00002142-200402000-00005
[19]   Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: Initial clinical results [J].
Padhani, AR ;
Hayes, C ;
Assersohn, L ;
Powles, T ;
Makris, A ;
Suckling, J ;
Leach, MO ;
Husband, JE .
RADIOLOGY, 2006, 239 (02) :361-374
[20]   Reproducibility of quantitative dynamic MRI of normal human tissues [J].
Padhani, AR ;
Hayes, C ;
Landau, S ;
Leach, MO .
NMR IN BIOMEDICINE, 2002, 15 (02) :143-153